Related Experiment Video
Updated: Nov 3, 2025

15:41
A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
Published on: October 15, 2013
15.1K
Microfluidic Based Physical Approaches towards Single-Cell Intracellular Delivery and Analysis.
Kiran Kaladharan1, Ashish Kumar1, Pallavi Gupta2
1Department of Engineering and System Science, National Tsing Hua University, Hsinchu 300044, Taiwan.
Micromachines
|June 2, 2021
Summary
Researchers review microfluidic physical methods for single-cell intracellular delivery, including electroporation and optoporation. These techniques offer high transfection efficiency and cell viability for advancing cell biology and personalized medicine.
Area of Science:
- Cell Biology
- Biotechnology
- Nanotechnology
Background:
- Delivering molecules into single cells is crucial for cell biology research, drug development, and diagnostics.
- Current bulk transfection methods lack efficiency and throughput for single-cell analysis.
- Understanding single-cell responses requires advanced intracellular delivery techniques.
Purpose of the Study:
- To review microfluidic-based physical methods for single-cell intracellular delivery.
- To analyze the mechanisms, applications, and limitations of these methods.
- To discuss the prospects of single-cell transfection technologies.
Main Methods:
- Electroporation
- Mechanoporation
- Microinjection
- Sonoporation
- Optoporation
- Magnetoporation
- Thermoporation
Main Results:
- Microfluidic methods enable precise control over intracellular delivery at the single-cell level.
- These techniques demonstrate high transfection efficiency and cell viability.
- Various physical methods offer distinct advantages for specific applications.
Conclusions:
- Microfluidic physical methods are promising for advancing single-cell analysis and personalized medicine.
- Further research is needed to overcome existing limitations and optimize these technologies.
- Single-cell intracellular delivery is key to understanding cellular processes and developing novel therapeutics.

